482 related articles for article (PubMed ID: 29165358)
1. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.
Bonilla X; Parmentier L; King B; Bezrukov F; Kaya G; Zoete V; Seplyarskiy VB; Sharpe HJ; McKee T; Letourneau A; Ribaux PG; Popadin K; Basset-Seguin N; Ben Chaabene R; Santoni FA; Andrianova MA; Guipponi M; Garieri M; Verdan C; Grosdemange K; Sumara O; Eilers M; Aifantis I; Michielin O; de Sauvage FJ; Antonarakis SE; Nikolaev SI
Nat Genet; 2016 Apr; 48(4):398-406. PubMed ID: 26950094
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations in basal cell carcinoma subtypes.
Di Nardo L; Pellegrini C; Di Stefani A; Ricci F; Fossati B; Del Regno L; Carbone C; Piro G; Corbo V; Delfino P; De Summa S; Maturo MG; Rocco T; Tortora G; Fargnoli MC; Peris K
Sci Rep; 2021 Jun; 11(1):13206. PubMed ID: 34168209
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
Reifenberger J; Wolter M; Knobbe CB; Köhler B; Schönicke A; Scharwächter C; Kumar K; Blaschke B; Ruzicka T; Reifenberger G
Br J Dermatol; 2005 Jan; 152(1):43-51. PubMed ID: 15656799
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors.
Kudchadkar R; Lewis K; Gonzalez R
Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185
[TBL] [Abstract][Full Text] [Related]
6. Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma.
Maturo MG; Rachakonda S; Heidenreich B; Pellegrini C; Srinivas N; Requena C; Serra-Guillen C; Llombart B; Sanmartin O; Guillen C; Di Nardo L; Peris K; Fargnoli MC; Nagore E; Kumar R
Sci Rep; 2020 May; 10(1):8005. PubMed ID: 32409749
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions.
Urman NM; Mirza A; Atwood SX; Whitson RJ; Sarin KY; Tang JY; Oro AE
PLoS One; 2016; 11(12):e0168031. PubMed ID: 28030567
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice.
Mancuso M; Pazzaglia S; Tanori M; Hahn H; Merola P; Rebessi S; Atkinson MJ; Di Majo V; Covelli V; Saran A
Cancer Res; 2004 Feb; 64(3):934-41. PubMed ID: 14871823
[TBL] [Abstract][Full Text] [Related]
9. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
[TBL] [Abstract][Full Text] [Related]
10. Nevoid Basal Cell Carcinoma Syndrome:
Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond.
Bakshi A; Chaudhary SC; Rana M; Elmets CA; Athar M
Mol Carcinog; 2017 Dec; 56(12):2543-2557. PubMed ID: 28574612
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Genetic Profile of BCC.
Cancer Discov; 2016 May; 6(5):OF2. PubMed ID: 27006369
[TBL] [Abstract][Full Text] [Related]
13. Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.
Wang GY; Wood CN; Dolorito JA; Libove E; Epstein EH
Oncogene; 2017 Jun; 36(26):3772-3780. PubMed ID: 28263978
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients.
Cho S; Hahm JH; Hong YS
Br J Dermatol; 2001 Apr; 144(4):841-8. PubMed ID: 11298546
[TBL] [Abstract][Full Text] [Related]
15. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma and the carcinogenic role of aberrant Hedgehog signaling.
Saran A
Future Oncol; 2010 Jun; 6(6):1003-14. PubMed ID: 20528237
[TBL] [Abstract][Full Text] [Related]
17. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma: a dermatopathological and molecular biological update.
Saldanha G; Fletcher A; Slater DN
Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
[TBL] [Abstract][Full Text] [Related]
19. Role of apoptosis in basal cell and squamous cell carcinoma formation.
Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
[TBL] [Abstract][Full Text] [Related]
20. Unique features of PTCH1 mutation spectrum in Chinese sporadic basal cell carcinoma.
Huang YS; Bu DF; Li XY; Ma ZH; Yang Y; Lin ZM; Lu FM; Tu P; Li H
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):235-41. PubMed ID: 22313357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
